XWELL (XWEL) Change In Payables And Accrued Expense : $-0.10 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is XWELL Change In Payables And Accrued Expense?

XWELL's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $0.91 Mil. It means XWELL's Accounts Payable & Accrued Expense increased by $0.91 Mil from Dec. 2023 to Mar. 2024 .

XWELL's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-0.49 Mil. It means XWELL's Accounts Payable & Accrued Expense declined by $0.49 Mil from Dec. 2022 to Dec. 2023 .

XWELL Change In Payables And Accrued Expense Historical Data

The historical data trend for XWELL's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XWELL Change In Payables And Accrued Expense Chart

XWELL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

3.76

-5.17

6.69

-3.25

-0.49

XWELL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.52	-0.33	-0.44	-0.24	0.91

XWELL Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

XWELL Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of XWELL's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (XWEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (NAS:XWEL) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

254 West 31st Street, 11th Floor, New York, NY, USA, 10001

Website

https://www.xwell.com

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

Executives

Suzanne A. Scrabis	officer: Chief Financial Officer	C/O XWELL, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Robert Weinstein	director	3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Scott R Milford	officer: Chief Executive Officer	C/O TOWN SPORTS INTERNATIONAL, LLC, 5 PENN PLAZA, NEW YORK NY 10001
Bruce Bernstein	director	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
Ezra Ernst	officer: See Remarks	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Omar Haynes	officer: VP Treas & Fi & Interim CFO	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Doug Satzman	director, officer: Chief Executive Officer	780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017
James A. Berry	officer: Chief Financial Officer	C/O XPRESSPA GROUP, INC., 254 WEST 31ST STREET, 11TH FLOOR, NEW YORK NY 10001
Michael Lebowitz	director	780 THIRD AVENUE, 12TH FLOOR, C/O XPRESSPA GROUP, INC., NEW YORK NY 10017
Donald E. Stout	director	780 THIRD AVENUE, 15TH FLOOR, NEW YORK NY 10017
Mistral Spa Holdings, Llc	10 percent owner	C/O MISTRAL CAPITAL MANAGEMENT, LLC, 650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Mistral Capital Management, Llc	10 percent owner	650 FIFTH AVENUE, 31ST FLOOR, NEW YORK NY 10019
Andrew R Heyer	other: Former director and 10% owner	501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Calm.com, Inc.	10 percent owner	140 2ND STREET, THIRD FLOOR, SAN FRANCISCO CA 94105
Edward Jankowski	officer: SVP; CEO of XpresSpa	C/O FORM HOLDINGS CORP., 780 THIRD AVENUE, 12TH FLOOR, NEW YORK NY 10017